NEW YORK — — With a focus on making the transition to a more secure, effective and affordable vaccine, Cephalon Biomedical Co. today announced it has signed a contract with the U.S. Food and Drug Administration (FDA) to establish a new company-owned and-operated vaccine testing and certification program for its newly launched cbaptide vaccine.The U.K.-based…